The Modulating Effect of Ursodeoxycholic Acid on Liver Tissue Cyclooxygenase-2 Expression Following Extended Hepatectomy.
cycloxygenase-2
experimental animal study
extended hepatectomy
liver regeneration
ursodeoxycholic acid
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
accepted:
07
06
2021
entrez:
16
7
2021
pubmed:
17
7
2021
medline:
17
7
2021
Statut:
epublish
Résumé
Hepatic regeneration is a complex process involving a multitude of well-timed molecular operations. Ursodeoxycholic acid (UDCA) is postulated to exert a protective effect against oxidative stress and enzymatic degradation of the extracellular matrix, in turn potentiating the regenerative response. The aim of the present animal study is to evaluate the impact of UDCA administration in liver tissue expression of cyclooxygenase-2 (COX-2) in a setting of acute liver failure achieved by 80% hepatectomy. Twenty-four adult male Sprague-Dawley rats were randomly assigned to an experimental (UDCA) and a control group. Animals in the UDCA received oral pretreatment with UDCA for 14 days via feeding tube, while animals in the control group received saline. All animals underwent resection of approximately 80% of the liver parenchyma. Tissue and blood sample collection were performed 48 hours postoperatively. The postoperative mitotic index and Ki-67 levels were found to be elevated in the UDCA group (43±11.4 and 13.7±24.7 versus 31±16.7 and 7.6±5.7), albeit without any statistical significance. Pretreatment with UDCA significantly decreased COX-2 expression levels (p=0.28) as well as serum tumor necrosis factor α (TNFα) levels (37.3±10.9 pg/mL versus 75.4±14.4 pg/mL, p=0.004). COX-2 expression score was observed to be weakly correlated to Ki-67 levels in both groups. Although COX-2 expression score was not correlated with serum TNFα levels in the control group, animals pretreated with UDCA exhibited moderate correlation (r=0.45). Preoperative administration of UDCA exerts a suppressive effect on tissue expression of COX-2 following 80% hepatectomy and enforces a positive correlation between COX-2 and serum TNFα levels, suggesting that UDCA preconditions liver tissue to display an enhanced regenerative response to circulating cytokines, most notably TNFα. The weak association of COX-2 with Ki-67 expression levels suggests that COX-2 may be of secondary importance during the early phases of liver regeneration.
Identifiants
pubmed: 34268031
doi: 10.7759/cureus.15500
pmc: PMC8262578
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e15500Informations de copyright
Copyright © 2021, Papakonstantinou et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cureus. 2020 Dec 17;12(12):e12120
pubmed: 33489534
Ann Surg. 2006 Jul;244(1):89-98
pubmed: 16794393
BMC Gastroenterol. 2013 Oct 30;13:155
pubmed: 24172289
Gastroenterology. 1993 Aug;105(2):495-9
pubmed: 8392956
Cancer Res. 2001 Dec 1;61(23):8564-8
pubmed: 11731443
Nutr Cancer. 2008;60(3):389-400
pubmed: 18444174
Cell Signal. 2019 Mar;55:65-72
pubmed: 30610893
Cell Growth Differ. 1999 Dec;10(12):819-28
pubmed: 10616907
World J Gastroenterol. 2002 Oct;8(5):815-7
pubmed: 12378621
Hepatology. 2006 Apr;43(4):826-36
pubmed: 16557554
Mol Med Rep. 2014 Oct;10(4):2177-83
pubmed: 25109894
FASEB J. 2001 Sep;15(11):2016-8
pubmed: 11511527
J Biol Chem. 2000 Sep 8;275(36):28028-32
pubmed: 10827178
Am J Physiol Gastrointest Liver Physiol. 2010 Oct;299(4):G887-97
pubmed: 20689055
Liver Int. 2008 Jan;28(1):3-11
pubmed: 18028319
Korean J Intern Med. 2010 Dec;25(4):364-71
pubmed: 21179273
Gastroenterology. 2005 Nov;129(5):1663-74
pubmed: 16285964
Surgery. 2001 Jan;129(1):48-54
pubmed: 11150033
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1441-6
pubmed: 9037072
PLoS One. 2017 Jun 30;12(6):e0180673
pubmed: 28665991
Nitric Oxide. 2005 Sep;13(2):111-7
pubmed: 16006158
Hepatol Res. 2009 Aug;39(8):814-21
pubmed: 19473430
Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G259-G271
pubmed: 29672156